Aculys: SoftBank's Masayoshi Son next big bet: Sleep disorder cures
Japan's Aculys Pharma LLC, backed by SoftBank's second Vision Fund, bought the rights to develop and sell pitolisant, used to treat narcolepsy and sleep apnea in Europe
Read full article »
Aculys is a Japan-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of neurological and psychiatric diseases.
Read more